[Pharmacologic properties of the antihistiminic 1-dimethylaminoethyl-2-alpha-pyridyl-4-oxo-1,2,3,4-tetrahydroquinazoline].
D000707:Anaphylaxis; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy*; D004361:Drug Tolerance; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006967:Hypersensitivity; D066298:In Vitro Techniques; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats
D000779:Anesthetics, Local; D006634:Histamine H1 Antagonists; D011799:Quinazolines
Pharmakologische Eigenschaften des Antihistaminicums 1-Dimethylaminoaethyl-2-alpha-pyridyl-4-oxo-1,2,3,4-tetrahydrochinazolin.